Medical Innovation Exchange

FDA flags Guillain-Barré risks for GSK, Pfizer RSV shots, but just one will need safety trial

https://www.fiercebiotech.com/biotech/fda-flags-guillain-barre-syndrome-risks-gsk-pfizer-rsk-vaccines-just-one-will-need-post

Leave a Comment

Your email address will not be published. Required fields are marked *

Leave the field below empty!